Trials / Unknown
UnknownNCT05046262
Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- Sponsor
- Bispebjerg Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
25 patients with primary low-risk basal cell carcinoma treated with calcium electroporation
Detailed description
25 patients with primary low-risk basal cell carcinoma treated with calcium electroporation, if partial or no response after 3 months the treatment was repeated. Follow-up 3 and 12 months after last treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Calcium chloride | Calcium electroporation |
Timeline
- Start date
- 2020-01-08
- Primary completion
- 2022-02-22
- Completion
- 2022-02-22
- First posted
- 2021-09-16
- Last updated
- 2021-09-16
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT05046262. Inclusion in this directory is not an endorsement.